Résumé
Background: Measles-rubella (MR) vaccination campaign was launched in India in a phasic manner. Maharashtra has launched this in November 2018. Objectives: This study was conducted to evaluate the coverage of MR vaccine in children aged 9–15 years in a rural area of Mohgaon village. Materials and Methods: A community-based cross-sectional study was carried out in the households of the rural village of Mohgaon, with 250 families and 390 eligible children in the age group of 9 months–15 years. Data were collected by the house-to-house visit. Results: Vaccination coverage was found to be 96.41%. Most of the children were in the age group of 6–15 years (74.46%) with no gender bias. Among vaccinated children, 56.25% and 94.27% had thumb mark and vaccination cards, respectively. Less than 5% of the children had minor side effects. Conclusion: Vaccination coverage in a rural area was found to be 96.41%, which is similar to the coverage found other states in an earlier phase.
Résumé
Rubella infection in pregnancy can lead to pathologies, including miscarriage, stillbirth and congenital rubella syndrome (CRS) in the neonate. Rubella vaccination can prevent all occurrences of CRS. In Sri Lanka, significant outbreaks of CRS occurred in 1994 and 1995, with 275 and 212 reported cases. In 1996, Sri Lanka introduced rubella vaccination for women aged 16–44 years, to stop CRS. Measles–rubella vaccine was introduced into the routine immunization schedule in 2001 and additional campaigns were carried out in 2003 (all 11–15 year olds) and 2004 (all 16–20 year olds). Reported immunization coverage with a single dose of a rubella-containing vaccine has been more than 95% since 2000. Laboratorysupported surveillance for rubella and CRS was started in 1992. Reported rubella cases fell from 364 (incidence 19/million population) in 1999 to 96 cases (incidence 5/million population) in 2002 and further to 12 cases (incidence 0.6/ million population) in 2014. Laboratory-supported CRS surveillance was started in 1990 and the highest number of CRS cases, 275 (incidence 77/100 000 live births), was diagnosed in 1994. Reported CRS cases fell from 22 cases (incidence 7/100 000 live births) in 2002 to 3 cases (incidence <1/100 000 live births) in 2014. Almost 20 years of routine rubella vaccination has resulted in >96% reduction in reported rubella cases and a corresponding >98% reduction in CRS cases. Despite this great achievement, work remains to eliminate rubella and CRS from Sri Lanka.
Résumé
Since the introduction of rubella vaccination in Korea in 1982, several outbreaks of rubella have occurred. In order to examine the current seroepidemiology of rubella virus infection in Korean women of child-bearing age, the healthy university women students of Yonsei University in Seoul aged 18 approximately 26 years were chosen as a model population. A survey was carried out in the time of routine annual physical check-up. Serum specimens of 242 volunteers of healthy women university students were randomly sampled for screening rubella-specific IgG/IgM antibodies by an automated enzyme immunoassay system (Vitek System VIDAS, bioMerieux Vitek, Inc., Lyon, France). A total of 177 subjects were positive for rubella-specific IgG antibody, giving a prevalence of 73.1%. The mean +/- standard deviation of rubella-specific IgG antibody was 99.3 +/- 95.3 IU/mL. In this study, the efficiency of a vaccination was about 88%. With such a relative high proportion of susceptibility (26.9%) among university women students in child-bearing age, a extensive rubella vaccination program should be enforced to prevent possible outbreaks of congenital rubella syndrome in the future.